Legal Opinion
American Sales Co. v. SmithKline Beecham Corp.
District Court, E.D. Pennsylvania
Decided November 12, 2010No. Civil Action No. 08-CV-03149PublishedCited by 2 opinions
1Opinion of the Court
MEMORANDUM
ANITA B. BRODY, District Judge.
Flonase is the brand-name version of fluticasone propionate (“FP”) — a nasal eorticos*130teroid produced by Defendant SmithKline Beecham Corporation d/b/a GlaxoSmithKline PLC (“GSK”). The Food and Drug Administration (“FDA”) approved Flonase to treat nasal inflammation caused by seasonal and non-seasonal allergies. Until recently, Flonase was one of the nation’s top-selling drugs, generating sales well over $1 billion in its peak years. This case concerns allegations that GSK restrained competition in violation of Section 2 of the Sherman Act, 15 U.S.C. §…
2Cases cited23 opinions
- Amchem Products, Inc. v. WindsorSupreme Court of the United States · 1997
- General Telephone Co. of Southwest v. FalconSupreme Court of the United States · 1982
- Zenith Radio Corp. v. Hazeltine Research, Inc.Supreme Court of the United States · 1969
- Eastman Kodak Co. v. Image Technical Services, Inc.Supreme Court of the United States · 1992
- In Re Hydrogen Peroxide Antitrust LitigationCourt of Appeals for the Third Circuit · 2009
18 more not listed; retrieve them via the Exa API.
3Cited by2 opinions
- In re Flonase Antitrust LitigationDistrict Court, E.D. Pennsylvania · 2012
- In re Flonase Antitrust LitigationDistrict Court, E.D. Pennsylvania · 2013